TOZORAKIMAB
UNII OHZ2MEL7FD

Substance Identification & Data

This profile provides standardized clinical and technical data for Tozorakimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OHZ2MEL7FD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2376858-66-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

OHZ2MEL7FD

CAS Registry Number

2376858-66-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TOZORAKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C179129

National Cancer Institute reference terminology for clinical and research data.

INN ID

11647

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-47

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tozorakimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOZORAKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 33) (HUMAN MONOCLONAL MEDI3506 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI3506 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS IL33 (INTERLEUKIN 33, DVS27, NF-HEV, IL1F11)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-456) (VH (HOMO SAPIENS IGHV3-23*01 (93.9%) -(IGHD) -IGHJ4*01 (85.7%) L123>M (121)) CDR-IMGT (8.8.19) (26-33.51-58.97-115) (1-126) -HOMO SAPIENS IGHG1*03 (100%) G1M3, NG1M1 (CH1 R120 (223) (127-224), HINGE 1-15 (225-239), CH2 (240-349), CH3 E12 (365), M14 (367) (350-454), CHS (455-456)) (127-456)), (229-211')-DISULFIDE WITH LAMBDA2 LIGHT CHAIN (1'-212') (V-LAMBDA (HOMO SAPIENS IGLV3-1*01 (86.2%) -IGLJ2*01 (100%)) CDR-IMGT (6.3.9) (26-31.49-51.88-96) (1'-106') -HOMO SAPIENS IGLC2*01 (100%) (107'-212')); DIMER (235-235'':238-238'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO) CELL LINE DERIVED FROM CHO-K1, GLYCOFORM ALFA

TOZORAKIMAB [INN]

TOZORAKIMAB [USAN]

TOZORAKIMAB [WHO-DD]